Advertisement

The Inflammatory Response — A Review

  • C. J. Dunn
  • D. A. Willoughby
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 87 / 1)

Abstract

The capacity for survival of an organism residues in part within its ability to recognise foreign or mechanically inflicted trauma. It is this “recognition” that triggers a series of events culminating in a host defence or inflammatory reaction which prompted John Hunter to describe inflammation as “a salutary process”.

Keywords

Migration Inhibitory Factor Polymorphonuclear Leukocyte Chemotactic Factor Mononuclear Leucocyte Leukocyte Emigration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Allison AC, Davies P (1974) Mechanisms underlying chronic inflammation. In:Velo GP, Willoughby DA, Giroud JP (eds) Future trends in inflammation. Piccin, Padua, pp 449–452Google Scholar
  2. Allison AC, Davies P (1975) Increased biochemical and biological activities of mononuclear phagocytes exposed to various stimuli, with special reference to secretion of lysosomal enzymes. In:VanFurth R (ed) Mononuclear phagocytes in immunity, infection, and pathology. Blackwell, Oxford, pp 487–506Google Scholar
  3. Allison F, Lancaster MG (1960) Studies on the pathogenesis of acute inflammation. II. The relationship of fibrinogen and fibrin to the leucocytic sticking reaction in ear chambers of rabbits injured by heat. J Exp Med 111:45–64PubMedGoogle Scholar
  4. Allison F, Smith MR, Wood WB (1955) Studies on the pathogenesis of acute inflammation. I. The inflammatory reaction to thermal injury as observed in the rabbit ear chamber. J Exp Med 102:655–667PubMedGoogle Scholar
  5. Altman LC, Snyderman R, Oppenheim JJ, Mergenhagen SE (1973) A human mononuclear leucocyte chemotactic factor:characterization, specificity and kinetics of production by homologous leukocytes. J Immunol 110:801–810PubMedGoogle Scholar
  6. Aswanikumar S, Corcoran B, Schiffmann E, Day AR, Freer RJ, Showell HJ, Becker EL, Pert CB (1977) Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem Biophys Res Commun 74:807–810Google Scholar
  7. Atherton A, Born GVR (1972) Quantitative investigations of the adhesiveness of circulating polymorphonuclear leucocytes to blood vessel walls. J Physiol (Lond) 222:447–474Google Scholar
  8. Babior BM, Kipnes RS, Curnutte JT (1973) Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52:741–744PubMedGoogle Scholar
  9. Bach MK, Brashler JR, Hammarstrom S, Samuelsson B (1980) Identification of leuko-triene C-1 as a major component of slow-reacting substance from rat mononuclear cells. J Immunol 125:115–117PubMedGoogle Scholar
  10. Barnhart MI (1968) Role of blood coagulation in acute inflammation. Biochem Pharmacol 16 (Suppl):206–219Google Scholar
  11. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618–623PubMedGoogle Scholar
  12. Billingham MEJ, Gordon AH (1976) The role of the acute phase reaction in inflammation. Agents Actions 6:195–200PubMedGoogle Scholar
  13. Bloom W (1922) Histamine as an inflammatory agent. Bull Johns Hopkins Hosp 33:185–188Google Scholar
  14. Borgeat P, Hamberg M, Samuelsson B (1977) Transformation of arachidonic acid and homo-γ-linolenic acid by rabbit polymorphonuclear leukocytes, monohydroxy acids from novel lipoxygenases. J Biol Chem 252:8772–8775Google Scholar
  15. Brune K, Glatt M, Kalin H, Peskar BA (1978) Pharmalogical control of prostaglandin and thromboxane release from macrophages. Nature 274:261–263PubMedGoogle Scholar
  16. Brune K, Aehringhaus U, Peskar BA (1984) Pharmacological control of leukotriene and prostaglandin production from mouse peritoneal macrophages. Agents Actions 14(5)(6):729–734PubMedGoogle Scholar
  17. Bryant RE, Sutcliffe MC (1974) The effect of 3′,5′-adenosine monophosphate on granulocyte adhesion. J Clin Invest 54:1241–1244PubMedGoogle Scholar
  18. Capasso F, Dunn CJ, Yamamoto S, Deporter DA, Giroud JP, Willoughby DA (1975) Pharmacological mediators of various immunological and non-immunological inflammatory reactions produced in the pleural cavity. Agents Actions 5:528–533PubMedGoogle Scholar
  19. Cardella CJ, Davies P, Allison AC (1974) Immune-compleyes induce selective release of lysosomal hydrolases from macrophages. Nature 247:46–48PubMedGoogle Scholar
  20. Chenoweth DE, Hugli TE (1978) Demonstration of specific C5A receptor on intact human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 75:3943–3947PubMedGoogle Scholar
  21. Clark ER, Clark EL (1935) Observations on changes in blood vascular endothelium in the living animal. Am J Anat 57:385–405Google Scholar
  22. Clark ER, Clark EL, Rex RO (1936) Observations on polymorphonuclear leukocytes in the living animal. Am J Anat 59:123–135Google Scholar
  23. Clark RAF, Gallin JI, Kaplan AP (1975) The selective eosinophil chemotactic activity of histamine. J Exp Med 142:1462–1476PubMedGoogle Scholar
  24. Clark RAF, Sandler JA, Gallin JI, Kaplan AP (1977) Histamine modulation of eosinophil migration. J Immunol 118:137–145PubMedGoogle Scholar
  25. Cochrane CG, Aiken BS (1966) Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro. J Exp Med 124:733–752PubMedGoogle Scholar
  26. Cohnheim J (1867) Über Entzündung und Eiterung. Arch Pathol Anat 40:1–49Google Scholar
  27. Cotran RS, Gimbrone MA, Bevilacqua MP, Mendrick DL, Pober JS (1986) In situ induction and detection of a human-endothelial cell activation antigen in immunological in-flammation. Fed Proc 45:379 Abstr no 1309Google Scholar
  28. Dale HH, Richards AN (1918) The vasodilator action of histamine and of some other substances. J Physiol 52:110–165PubMedGoogle Scholar
  29. Davies P, Allison AC, Ackerman J, Butterfield A, Williams S (1974 a) Asbestos induces release of lysosomal enzymes from mononuclear phagocytes. Nature 251:423–425PubMedGoogle Scholar
  30. Davies P, Page RC, Allison AC (1974 b) Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med 139:1262–1282PubMedGoogle Scholar
  31. DiRosa M, Giroud JP, Willoughby DA (1971) Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol 104:15–29Google Scholar
  32. Dormandy TL (1978) Free-radical oxidation and antioxidants. Lancet 1:647–650PubMedGoogle Scholar
  33. Dumonde DC, Wolstencroft RA, Panayi GS, Matthew M, Morley J, Howson WT (1969) Lymphokines:non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature 224:38–42PubMedGoogle Scholar
  34. Dunn CJ, Fleming WE (1984) Increased adhesion of polymorphonuclear leukocytes to vascular endothelium by specific interaction of endogenous (interleukin-1) and exogenous (lipopolysaccharide) substances with endothelial cells in vitro. Eur J Rheumatol Inflamm 7:80–86PubMedGoogle Scholar
  35. Dunn CJ, Fleming WE (1985) The role of interleukin-1 in the inflammatory response with particular reference to endothelial cell-leukocyte adhesion. In:Kluger MJ, Oppenheim JJ, Powanda MC (eds) Progress in leukocyte biology. Liss, New York, pp 45–54Google Scholar
  36. Dunn CJ, Gibbons AJ (1987) Human recombinant interleukin-1 induces chronic granulomatous inflammation. J Leukocyte Biol 42:615Google Scholar
  37. Dunn CJ, Willoughby DA (1981) Leukocyte and macrophage migration inhibitory activities in inflammatory exudates — involvement of the coagulation system. Lymphokines 4:231–269Google Scholar
  38. Dunn CJ, Giroud JP, Willoughby DA (1976) Cellular pharmacokinetics in inflammation. In:Huskisson EC, Velo GP (eds) Inflammatory arthropathies. Excerpta Medica, Am-sterdam, pp 23–30Google Scholar
  39. Dunn CJ, Schaub RG, Fleming WE, Gibbons AJ (1987) Vascular changes induced by interleukin 1 in vivo:scanning electron microscope studies. In:Movat HZ (ed) Leukocyte emigration and its sequelae. Karger, Basel, pp 58–61Google Scholar
  40. Emeis JJ, Kooistra T (1986) Interleukin-1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med 163:1260–1266PubMedGoogle Scholar
  41. Estensen RD, Hill HR, Quie PG, Gogan N, Goldberg ND (1973) Cyclic GMP and cell movement. Nature 254:458–460Google Scholar
  42. Fantone JC, Ward PA (1982) Role of oxygen-derived free radicals and metabolites in leu-kocyte-dependent inflammatory reactions. Am J Pathol 107 (3):396–418Google Scholar
  43. Ferreira SH (1972) Prostaglandins, aspirin-like drugs and analgesia. Nature 240:200–203Google Scholar
  44. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJH (1980) Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264–265PubMedGoogle Scholar
  45. Ford-Hutchinson AW, Brunet G, Savard P, Charleson S (1984) Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat. Prostaglandins 28 (1):13–27PubMedGoogle Scholar
  46. Fritz H (1978) Necessity of a critical consideration of the homogeneity PMH proteases applied to biological assay systems:failure to detect intrinsic kininogenase activity in PMH elastase. In:Havemann K, Janoff A (eds) Neutral proteases of human polymorphonuclear leukocytes — biochemistry, physiology, and clinical significance. Urban and Schwarzenberg, Baltimore, pp 261–263Google Scholar
  47. Gallin EK, Gallin JI (1977) Electrophysiology of human macrophage interaction with chemotactic factors. J Cell Biol 75:277–289PubMedGoogle Scholar
  48. Gallin EK, Wiederhold ML, Lipsky PE, Rosenthal AS (1975) Spontaneous and induced membrane hyperpolarizations in macrophages. J Cell Physiol 86:653–661PubMedGoogle Scholar
  49. Gallin EK, Seligmann BE, Gallin JI (1980) Alteration of macrophage and monocyte membrane potential by chemotactic factors. In:VanFurth R (ed) Mononuclear phagocytes — functional aspects. Martinus Nijhoff, The Hague, pp 505–526Google Scholar
  50. Gallin JI, Durocher JR, Kaplan AP (1975) Interaction of leukocyte chemotactic factors with cell surface. 1. Chemotactic factor-induced changes in human granulocyte surface charge. J Clin Invest 55:967–974PubMedGoogle Scholar
  51. Gallin JI, Gallin EK, Shiffmann E (1979) Mechanism of leukocyte chemotaxis. In:Paoletti R, Samuelson B, Weissmann G (eds) Advances in inflammation research. Raven, New York, pp 123–138Google Scholar
  52. Gallin JI, Wright DG, Malech HL, Davis JM, Klempner MS, Kirkpatrick CH (1980) Dis-orders of phagocyte chemotaxis. Ann Intern Med 92:520–538PubMedGoogle Scholar
  53. Gemsa D, Steggemann L, Till G, Resch K (1977) Enhancement of PGE1 response of macrophages by concanavalin-A and colchicine. J Immunol 119:524–529PubMedGoogle Scholar
  54. Glenn EM, Bowman BJ, Koslowske TC (1968) The systemic response to inflammation. Biochem Pharmacol 16 (Suppl):27–49Google Scholar
  55. Goetzl EJ, Austen KF (1975) Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue:identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci USA 72:4123–4127PubMedGoogle Scholar
  56. Goldstein IM, Kaplan HB, Edelson HS, Weissmann G (1979) Ceruloplasmin. A scavenger of superoxide anion radicals. J Biol Chem 254:4040–4045PubMedGoogle Scholar
  57. Gordon D, Bray MA, Morley J (1976) Control of lymphokine secretion by prostaglandins. Nature 262:401–402PubMedGoogle Scholar
  58. Goto K, Nakamura S, Goto F, Yoshinaga M (1984) Generation of an interleukin-I-like lymphocyte-stimulating factor at inflammatory sites:correlation with the infiltration of polymorphonuclear leucocytes. Br J Exp Pathol 65:521–532PubMedGoogle Scholar
  59. Hashimoto K, Shafran KM, Webber PS, Lazarus GS, Singer KJ (1983) Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion. J Exp Med 157:259–272PubMedGoogle Scholar
  60. Henson PM (1969) The adherence of leucocytes and platelets induced by fixed IgG antibody or complement. Immunology 16:107–121PubMedGoogle Scholar
  61. Henson PM, Johnson HB, Spiegelberg HL (1972) The release of granule enzymes from human neutrophils stimulated by aggregated immunoglobulins of different classes and subclasses. J Immunol 109:1182–1192PubMedGoogle Scholar
  62. Hoover RL, Briggs RT, Karnovsky MJ (1978) The adhesive interaction between polymorphonuclear leucocytes and endothelial cells in vitro. Cell 14:423–428PubMedGoogle Scholar
  63. Hoover RL, Karnovsky MJ, Austen KF, Corey EJ, Lewis RA (1984) Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion. Proc Natl Acad Sci USA 81:2191–2193PubMedGoogle Scholar
  64. Hudig D, Sell S (1978) Serum concentrations of alpha-macro fetoprotein (acute-phase alpha-2-macroglobulin), a proteinase inhibitor, in pregnant and neonatal rats and in rats with acute inflammation. Inflammation 3 (2):137–148PubMedGoogle Scholar
  65. Hugli TE, Taylor JC, Crawford JP (1976) Selective cleavage of human C3 by human leukocyte elastase (HLE). J Immunol 116:1737–1739Google Scholar
  66. Hunter J (1794) In:A treatise on the blood, inflammation and gunshot wounds. Richardson, LondonGoogle Scholar
  67. Hurley JV (1964) Substances promoting leukocyte emigration. Ann NY Acad Sci 116:918–935PubMedGoogle Scholar
  68. Issekutz AC, Megyeri P (1987) Induction of leukocyte infiltration by endotoxin. In:Movat HZ (ed) Leukocyte emigration. Karger, Basel, pp 24–37Google Scholar
  69. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF (1980) Complement induction of granulocyte aggregation:an unsuspected mechanism of disease. N Engl J Med 302:789–794PubMedGoogle Scholar
  70. Janoff A (1972) Human granulocyte elastase. Further delineation of its role in connective tissue damage. Am J Pathol 68:579–592PubMedGoogle Scholar
  71. Johnson RL, Ziff M (1976) Lymphokine stimulation of collagen accumulation. J Clin Invest 58(1):240–252PubMedGoogle Scholar
  72. Johnston RB Jr, Stroud RM (1977) Complement and host defense against infection. J Pediatr 90:169–179PubMedGoogle Scholar
  73. Kampschmidt RF (1984) The numerous postulated biological manifestations of interleukin-1. J Leukocyte Biol 36:341–355PubMedGoogle Scholar
  74. Klebanoff SJ (1968) Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95:2131–2138PubMedGoogle Scholar
  75. Klebanoff SJ, Hamon CB (1972) Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12:170–196PubMedGoogle Scholar
  76. Krakauer T, Oppenheim J J, Jasin HE (1985) Human interleukin 1 intermediates cartilage matrix degradation. Cell Immunol 91(1):92–99PubMedGoogle Scholar
  77. Lazarus GS (1973) Studies on the degradation of collagen by collagenases. In:Dingle JT (ed) Lysosomes in biology and pathology, vol 3. North-Holland, Amsterdam, pp 338–364Google Scholar
  78. Lentnek AL, Schreiber AD, MacGregor RR (1976) The induction of augmented granulocyte adherence by inflammation. Mediation by a plasma factor. J Clin Invest 57:1098–1103PubMedGoogle Scholar
  79. Luger TA, Charon J A, Colot M, Micksche M, Oppenheim JJ (1983) Chemotactic properties of partially purified human epidermal cell-derived thymocyte-activating factor (ETAF) for polymorphonuclear and mononuclear cells. J Immunol 131 (2):816–820PubMedGoogle Scholar
  80. Lyman WD, Roth GA, Chui FC, Brosnan CF, Bornstein MB, Raine CS (1986) Antigen specific T cells can mediate demyelination in organotypic central nervous system cultures. Cell Immunol 102:217–226PubMedGoogle Scholar
  81. MacGregor RR (1976) Cyclic nucleotide induction as a mechanism for modification of granulocyte adherence (GA) by plasma factors. Clin Res 24:348AGoogle Scholar
  82. MacGregor RR (1977) Granulocyte adherence changes induced by hemodialysis, endotoxin epinephrine, and glucocorticoids. Ann Intern Med 86:35–39Google Scholar
  83. MacGregor RR, Macarak EJ, Kefalides NA (1978 a) Comparative adherence of granulocytes to endothelial monolayers and nylon fiber. J Clin Invest 61:697–702PubMedGoogle Scholar
  84. MacGregor RR, Negendank WB, Schreiber AD (1978 b) Impaired granulocyte adherence in multiple myeloma: relationship to complement system, granulocyte delivery, and infection. Blood 51:591–599PubMedGoogle Scholar
  85. Mackay AR, Sedgwick AD, Dunn CJ, Fleming WE, Willoughby DA (1985) The transition from acute to chronic inflammation. Br J Dermatol 113 (Suppl 28):34–48PubMedGoogle Scholar
  86. Mayer MM (1973) The complement system. Sci Am 229:54–66PubMedGoogle Scholar
  87. Metzger WJ, Richerson HB, Waserman SI (1986) Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic responses. J Allergy Clin Immunol 78:282–290PubMedGoogle Scholar
  88. Montesano R, Mossaz A, Ryser JE, Orci L, Vassalli P (1984) Leukocyte interleukin induced cultured endothelial cells to produce a highly organized, glycosaminoglycan-rich pericellular matrix. J Cell Biol 99:1706–1715PubMedGoogle Scholar
  89. Morley J (1981) Role of prostaglandins secreted by macrophages in the inflammatory process. Lymphokines 4:377–394Google Scholar
  90. Nawroth PP, Stern DM (1986 a) Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 163:740–746PubMedGoogle Scholar
  91. Nawroth PP, Handley DA, Esmon CT, Stern DM (1986 b) Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 83:3460–3464PubMedGoogle Scholar
  92. O’Dea R, Viveros OH, Axelrod J, Awanikaumar S, Schiffmann E, Corcoran BA (1978) Rapid stimulation of protein carboxymethylation in leukocytes by a chemotactic peptide. Nature 272:462–465PubMedGoogle Scholar
  93. O’Flaherty JT, Craddock PR, Jacob HS (1978) Effect of intravascular complement activation on granulocyte adhesiveness and distribution. Blood 51:731–733PubMedGoogle Scholar
  94. Oppenheim JJ, Charon J A, Luger TA (1982) Evidence for an in vivo inflammatory role of interleukin 1 (IL-1). Transplant Res 14:553–557Google Scholar
  95. Passwell JH, Dayer JM, Merler E (1979) Increased prostaglandin production by human monocytes after membrane receptor activation. J Immunol 123:115–117PubMedGoogle Scholar
  96. Pearson JD, Carleton JS, Beesley JE, Hutchings A, Gordon JL (1979) Granulocyte adhesion to endothelium in culture. J Cell Sci 38:225–231PubMedGoogle Scholar
  97. Perillie PE, Nolan JP, Finch SC (1962) Studies of the resistance to infection in diabetes mellitus:local exudate cellular response. J Lab Clin Med 59:1008–1012PubMedGoogle Scholar
  98. Pettipher ER, Higgs GA, Henderson BA (1986) Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83:8749–8752PubMedGoogle Scholar
  99. Pick E (1976) The mechanism of action of macrophage migration inhibitory factor (MIF). A personal view. Curr Titles Immunol 4:565–568Google Scholar
  100. Pike MC, Kredich NM, Snyderman R (1978) Requirement of S-adenosyl-L-methionine-mediated methylation for human monocyte chemotaxis. Proc Natl Acad Sci USA 75:3928–3930PubMedGoogle Scholar
  101. Plow EF, Edgington TS (1975) An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen leukocyte proteases at physiologic pH. J Clin Invest 56:30–35PubMedGoogle Scholar
  102. Pohlman TH, Stanness KA, Beatty PG, Ochs HD, Harlan JM (1986) An endothelial cell surface factor(s) induced in vitro by lipopolysaccharide, interleukin 1, and tumor necrosis factor-alpha increases neutrophil adherence by a CDwl8-dependent mechanism. J Immunol 136:4548–4551PubMedGoogle Scholar
  103. Prendergast RA, Lutty GA, Dinarello CA (1987) Interleukin-1 induces corneal neovascularization. Fed Proc 46:1200Google Scholar
  104. Rapport MM, Green AA, Page IH (1948) Crystalline serotonin. Science 108:329–330PubMedGoogle Scholar
  105. Riddle JM, Odle NA, Bluhm GB, Barnhart MI (1967) Leucocyte-fibrin interactions. Thromb Diath Haemorrh 18:302–303Google Scholar
  106. Rowley DA, Benditt EP (1956) 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med 103:399–411PubMedGoogle Scholar
  107. Saklatvala J (1986) Tumor necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 32:547–550Google Scholar
  108. Salin ML, McCord JM (1974) Superoxide dismutases in polymorphonuclear leukocytes. J Clin Invest 54:1005–1009PubMedGoogle Scholar
  109. Samuelsson B (1981) Leukotrienes:mediators of allergic reactions and inflammation. Int Arch Allergy Appl Immunol 66(1):98–101PubMedGoogle Scholar
  110. Schultz DR (1978) Mediators of the inflammatory process. In:Talbott JH (ed) Fundamental and clinical aspects of internal medicine. Elsevier, Amsterdam, pp 27–35Google Scholar
  111. Seligmann B, Gallin EK, Martin DL, Shain W, Gallin JI (1977) Evidence of membrane potential changes in human polymorphonuclear leukocytes during exposure to the chemotactic factor formylemethionylleucylphenyl alanine as measured with the fluorescent dye DI pentyloxa carbo cyanine. J Cell Biol 75:103aGoogle Scholar
  112. Shalaby MR, Pennica D, Palladino MA Jr (1986) An overview of the history and biologic properties of tumor necrosis factor. Springer Semin Immunopathol 9:33–38PubMedGoogle Scholar
  113. Shevach EM, Jaffe ES, Green I (1973) Receptors for complement and immunoglobulin on human and animal lymphoid cells. Transplant Rev 16:3–11PubMedGoogle Scholar
  114. Smith MJ, Ford-Hutchinson AW, Bray MA (1980) Leukotriene B, a potential mediator of inflammation. J Pharm Pharmacol 32:517–521PubMedGoogle Scholar
  115. Smith RJ, Ignarro LJ (1975) Bioregulation of lysosomal enzyme secretion from human neutrophils:roles of guanosine 3′5′-monophosphate and calcium in stimulus-secretion coupling. Proc Natl Acad Sci USA 72 (1):108–111PubMedGoogle Scholar
  116. Snyderman R, Goetzl EJ (1981) Molecular and cellular mechanisms of leukocyte chemotaxis. Science 213:830–833PubMedGoogle Scholar
  117. Solomon A (1978) Possible role of PMN proteases in immunoglobulin degradation and amyloid formation. In:Havemann K, Janoff A (eds) Neutral proteases of human polymorphonuclear leukocytes. Urban and Schwarzenberg, Baltimore, pp 423–436Google Scholar
  118. Soter NA, Austen FK (1977) Urticaria, angioedema, and mediator release in humans in response to physical environmental stimuli. Fed Proc 36:1736–1739PubMedGoogle Scholar
  119. Spector WG (1951) The role of some higher peptides in inflammation. J Pathol Bacteriol 63:93–97PubMedGoogle Scholar
  120. Spilberg I, Mehta J (1979) Demonstration of a specific neutrophil receptor for a cell-de-rived chemotactic factor. J Clin Invest 63:85–90PubMedGoogle Scholar
  121. Spilberg I, Gallacher J, Mehta JM, Mandell B (1976) Urate crystal-induced chemotactic factor:isolation and partial characterization. J Clin Invest 58:815–820Google Scholar
  122. Starkey PM, Barrett AJ, Burleigh MC (1977) The degradation of articular collagen by neutrophil proteinases. Biochim Biophys Acta 483:386–389PubMedGoogle Scholar
  123. Stastny P, Ziff M (1970) Inhibitor of macrophage migration produced by polymorphonuclear leucocytes. J Reticuloendothel Soc 7:140–145PubMedGoogle Scholar
  124. Steele L, Hunneyball IM, Mason CG (1984) Contribution of LTB4 to leukocyte migration in inflammatory lesions. J Pharm Pharmacol 36:644–647PubMedGoogle Scholar
  125. Thomson B, Saklatvala J, Chambers TJ (1985) The effect of interleukin 1 (Catabolin) on bone resorption by disaggregated osteoclasts. Lymphokine Res 4 (1):75Google Scholar
  126. Wahl LM, Ohlsen CE, Sandberg AL, Mergenhagen SE (1977) Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci USA 74:4955–4958PubMedGoogle Scholar
  127. Wasserman SI, Soter NA, Center DM, Austen KF (1977) Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge. J Clin Invest 60:189–194PubMedGoogle Scholar
  128. Wedmore CV, Williams TJ (1981) Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289:646–648PubMedGoogle Scholar
  129. Weissmann G, Korchak HM, Perez HD, Smolen JE, Goldstein IM, Hoffstein ST (1979) The secretory code of the neutrophil. J Reticuloendothel Soc 26:687–691PubMedGoogle Scholar
  130. Werb Z, Gordon S (1975 a) Secretion of a specific collagenase by stimulated macrophages. J Exp Med 142:346–350PubMedGoogle Scholar
  131. Werb Z, Gordon S ( 1975 b) Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med 142:361–367PubMedGoogle Scholar
  132. Williams LT, Snyderman R, Pike MC, Lefkowitz RJ (1977) Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 74:1204–1207PubMedGoogle Scholar
  133. Williams TJ, Morley J (1973) Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246:215–218PubMedGoogle Scholar
  134. Williams TJ, Piper PJ (1980) The action of chemically pure SRS-A on the microcirculation in vivo. Prostaglandins 19:779–782PubMedGoogle Scholar
  135. Willoughby DA, DiRosa M (1970) A unifying concept for inflammation:a new appraisal of some old mediators. Exeerpta Medica Int Congr Ser 229:28–38Google Scholar
  136. Willoughby DA, Polak L, Turk JL (1968) Suppression of contact hypersensitivity and acute inflammation by anti-complement serum. Nature 219:192–194PubMedGoogle Scholar
  137. Willoughby DA, Coote E, Turk JL (1969) Complement in acute inflammation. J Pathol 97:295–301PubMedGoogle Scholar
  138. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL (1983) Isolation of an interleukin-l-like factor from human joint effusions. Arthritis Rheum 26 (8):975–978PubMedGoogle Scholar
  139. Yamamoto S, Dunn CJ, Deporter DA, Capasso F, Willoughby DA, Huskinsson EC (1975) A model for the quantitative study of Arthus (immunologic) hypersensitivity in rats. Agents Actions 5:374–377PubMedGoogle Scholar
  140. Yamamoto S, Dunn CJ, Willoughby DA (1976 a) Studies on delayed hypersensitivity pleural exudates in guinea pigs. I. Demonstration of substances in the cell-free exudate which cause inhibition of mononuclear cell migration in vitro. Immunology 30:505–511PubMedGoogle Scholar
  141. Yamamoto S, Dunn CJ, Willoughby DA (1976 b) Studies on delayed hypersensitivity pleural exudates in guinea pigs. II. The interrelationship of monocytic and lymphocytic cells with respect to migration activity. Immunology 30:513–519PubMedGoogle Scholar
  142. Yoshida T, Bigazzi PE, Cohen S (1975) Biologic and antigenic similarity of virus-induced migration inhibition factor in conventional, lymphocyte-derived migration inhibition factor. Proc Natl Acad Sci USA 72:1641–1643PubMedGoogle Scholar
  143. Ziff M (1983) Factors involved in cartilage injury. J Rheumatol (Suppl) 11:13Google Scholar
  144. Zigmond SH (1977) The ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factor. J Cell Biol 75:606–610PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • C. J. Dunn
  • D. A. Willoughby

There are no affiliations available

Personalised recommendations